The effect of cardiovascular diseases on the course of multiple sclerosis (review of literature)
Comorbidity is one of the factors determining the course of multiple sclerosis. Cardiovascular pathology is one of the most common in the population as a whole, especially in age groups over 50. Several studies showed that arterial hypotension and dyslipidemia affected the course, progression rate,...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Academician I.P. Pavlov First St. Petersburg State Medical University
2020-02-01
|
| Series: | Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова |
| Subjects: | |
| Online Access: | https://www.sci-notes.ru/jour/article/view/613 |
| _version_ | 1797697551392047104 |
|---|---|
| author | N. A. Neofidov N. A. Totolyan M. V. Shumilina A. A. Skoromets E. P. Evdoshenko |
| author_facet | N. A. Neofidov N. A. Totolyan M. V. Shumilina A. A. Skoromets E. P. Evdoshenko |
| author_sort | N. A. Neofidov |
| collection | DOAJ |
| description | Comorbidity is one of the factors determining the course of multiple sclerosis. Cardiovascular pathology is one of the most common in the population as a whole, especially in age groups over 50. Several studies showed that arterial hypotension and dyslipidemia affected the course, progression rate, and neuroimaging characteristics of patients with multiple sclerosis. An important issue is the effect of disease modifying therapy on the course of concomitant diseases in patients with multiple sclerosis and the effect of concomitant diseases on the effectiveness and safety of disease modifying therapy. The question of the use of statins in multiple sclerosis remains controversial. This review presents data on vascular comorbidity in multiple sclerosis, including the prevalence of risk factors for cardiovascular pathology and concomitant vascular diseases in the population of patients with multiple sclerosis. Data on the effect of cardiovascular pathology on the course and treatment of multiple sclerosis were also analyzed. |
| first_indexed | 2024-03-12T03:41:49Z |
| format | Article |
| id | doaj.art-8fe04642dc6f4b3bb6a0b3997fb38e22 |
| institution | Directory Open Access Journal |
| issn | 1607-4181 |
| language | Russian |
| last_indexed | 2024-03-12T03:41:49Z |
| publishDate | 2020-02-01 |
| publisher | Academician I.P. Pavlov First St. Petersburg State Medical University |
| record_format | Article |
| series | Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова |
| spelling | doaj.art-8fe04642dc6f4b3bb6a0b3997fb38e222023-09-03T13:02:35ZrusAcademician I.P. Pavlov First St. Petersburg State Medical UniversityУчёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова1607-41812020-02-01263314210.24884/1607-4181-2019-26-3-31-42472The effect of cardiovascular diseases on the course of multiple sclerosis (review of literature)N. A. Neofidov0N. A. Totolyan1M. V. Shumilina2A. A. Skoromets3E. P. Evdoshenko4City Clinical Hospital № 31, City Center for Multiple Sclerosis and Other Autoimmune Diseases; Pavlov UniversityPavlov UniversityCity Clinical Hospital № 31, City Center for Multiple Sclerosis and Other Autoimmune Diseases; Pavlov UniversityPavlov UniversityCity Clinical Hospital № 31, City Center for Multiple Sclerosis and Other Autoimmune Diseases; Pavlov UniversityComorbidity is one of the factors determining the course of multiple sclerosis. Cardiovascular pathology is one of the most common in the population as a whole, especially in age groups over 50. Several studies showed that arterial hypotension and dyslipidemia affected the course, progression rate, and neuroimaging characteristics of patients with multiple sclerosis. An important issue is the effect of disease modifying therapy on the course of concomitant diseases in patients with multiple sclerosis and the effect of concomitant diseases on the effectiveness and safety of disease modifying therapy. The question of the use of statins in multiple sclerosis remains controversial. This review presents data on vascular comorbidity in multiple sclerosis, including the prevalence of risk factors for cardiovascular pathology and concomitant vascular diseases in the population of patients with multiple sclerosis. Data on the effect of cardiovascular pathology on the course and treatment of multiple sclerosis were also analyzed.https://www.sci-notes.ru/jour/article/view/613multiple sclerosiscomorbidityvascular comorbidityhypertensionstrokechronic heart failureischemic heart diseasemyocardial infarctiondyslipidemiaobesity |
| spellingShingle | N. A. Neofidov N. A. Totolyan M. V. Shumilina A. A. Skoromets E. P. Evdoshenko The effect of cardiovascular diseases on the course of multiple sclerosis (review of literature) Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова multiple sclerosis comorbidity vascular comorbidity hypertension stroke chronic heart failure ischemic heart disease myocardial infarction dyslipidemia obesity |
| title | The effect of cardiovascular diseases on the course of multiple sclerosis (review of literature) |
| title_full | The effect of cardiovascular diseases on the course of multiple sclerosis (review of literature) |
| title_fullStr | The effect of cardiovascular diseases on the course of multiple sclerosis (review of literature) |
| title_full_unstemmed | The effect of cardiovascular diseases on the course of multiple sclerosis (review of literature) |
| title_short | The effect of cardiovascular diseases on the course of multiple sclerosis (review of literature) |
| title_sort | effect of cardiovascular diseases on the course of multiple sclerosis review of literature |
| topic | multiple sclerosis comorbidity vascular comorbidity hypertension stroke chronic heart failure ischemic heart disease myocardial infarction dyslipidemia obesity |
| url | https://www.sci-notes.ru/jour/article/view/613 |
| work_keys_str_mv | AT naneofidov theeffectofcardiovasculardiseasesonthecourseofmultiplesclerosisreviewofliterature AT natotolyan theeffectofcardiovasculardiseasesonthecourseofmultiplesclerosisreviewofliterature AT mvshumilina theeffectofcardiovasculardiseasesonthecourseofmultiplesclerosisreviewofliterature AT aaskoromets theeffectofcardiovasculardiseasesonthecourseofmultiplesclerosisreviewofliterature AT epevdoshenko theeffectofcardiovasculardiseasesonthecourseofmultiplesclerosisreviewofliterature AT naneofidov effectofcardiovasculardiseasesonthecourseofmultiplesclerosisreviewofliterature AT natotolyan effectofcardiovasculardiseasesonthecourseofmultiplesclerosisreviewofliterature AT mvshumilina effectofcardiovasculardiseasesonthecourseofmultiplesclerosisreviewofliterature AT aaskoromets effectofcardiovasculardiseasesonthecourseofmultiplesclerosisreviewofliterature AT epevdoshenko effectofcardiovasculardiseasesonthecourseofmultiplesclerosisreviewofliterature |